Eli Lilly and Company is set to significantly cut its environmental footprint by replacing the 90 billion paper inserts used annually in pharmaceutical packaging with digital alternatives. According to Diogo Rau, the company’s executive vice president and chief information and digital officer, this shift not only promotes environmental sustainability but also enhances accessibility for patients. Many individuals face challenges such as vision impairments, language barriers, or cognitive and physical disabilities, which can make traditional paper inserts difficult to use. The new digital formats will offer customizable options, multilingual translations, and features to assist those with disabilities, aligning with the pharmaceutical industry’s broader efforts to focus on patient-centric care while decreasing waste.
How is Eli Lilly improving accessibility with digital alternatives?
